pinocembrin has been researched along with Depression in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, T; Jiang, CL; Li, JM; Wang, W | 1 |
Li, G; Li, L; Li, Z; Liang, S; Liu, S; Su, R; Xu, C; Xu, X; Yang, J; Yang, R; Zou, L | 1 |
Gu, X; Tu, J; Wang, W; Xu, L; Zheng, L | 1 |
3 other study(ies) available for pinocembrin and Depression
Article | Year |
---|---|
Pinocembrin ameliorates depressive-like behaviors by regulating P2X7/TRL4 receptors expression in mouse hippocampus.
Topics: Animals; Behavior, Animal; Cytokines; Depression; Depressive Disorder, Major; Disease Models, Animal; Flavanones; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Purinergic P2X7; Stress, Psychological; Toll-Like Receptor 4 | 2022 |
Pinocembrin Inhibits P2X4 Receptor-Mediated Pyroptosis in Hippocampus to Alleviate the Behaviours of Chronic Pain and Depression Comorbidity in Rats.
Topics: Adenosine Triphosphate; Animals; Chronic Pain; Comorbidity; Connexin 43; Depression; HEK293 Cells; Hippocampus; Humans; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; RNA, Messenger | 2022 |
Pinocembrin mitigates depressive-like behaviors induced by chronic unpredictable mild stress through ameliorating neuroinflammation and apoptosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Apoptosis; Behavior, Animal; Cytokines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Flavanones; Hippocampus; Male; Mice; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Stress, Psychological | 2020 |